Scholarlink

Purpose <p>To appraise financial toxicity (FT) among women receiving care for breast cancer during the COVID-19 pandemic and determine sociodemographic, clinical, psychosocial, and care-disruption factors linked to greater financial hardship.</p> Methods <p>Forty-eight survivors (mean age = 45.3 ± 10.9&#xa0;years; 42% Black, 42% non-Hispanic White, 17% Hispanic/Latina) completed an online survey. FT was measured with the COST-FACIT. Additional instruments assessed perceived stress (PSS-10), coping (Brief-COPE), self-efficacy (CBI-B), social isolation (PROMIS-SF-4a), health-related quality of life (FACT-B), and pandemic-related delays or changes in cancer care. Pearson correlations explored bivariate associations; backward-selection regression identified predictors of FT.</p> Results <p>Mean COST score was 21.77 ± 12.33 and 58.3% of survivors met the threshold for mild or moderate FT (&lt; 26). Worse FT correlated with higher psychological distress (<i>p</i> = 0.001), greater social isolation (<i>p</i> = 0.005), and more care disruptions (<i>p</i> &lt; 0.001). Financial security correlated with greater self-efficacy (<i>p</i> = 0.019) and higher health-related quality of life (<i>p</i> &lt; 0.001). In multiple regression analysis (R<sup>2</sup> = 0.69), survivors reporting worse quality of life, lower income, and less education reported greater financial toxicity.</p> Conclusions <p>Breast cancer survivors experienced substantial FT while navigating care during the pandemic, with greater burden associated with psychological distress, social isolation, care disruptions, and lower socioeconomic status. FT was attenuated among those with higher health-related quality of life and self-efficacy. Integrating proactive financial navigation, psychosocial screening, and targeted support for socioeconomically vulnerable survivors into routine oncology care may mitigate financial hardship and improve overall well-being.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Financial toxicity among breast cancer survivors receiving care during the pandemic

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月6日

查看全文
  • Chiara Acquati,
  • Tzuan A. Chen,
  • Chelsea Sanchez,
  • Isabel Martinez Leal,
  • Anastasia Rogova,
  • Shahnjayla K. Connors,
  • Matthew P. Banegas,
  • Grace Smith,
  • Lorraine R. Reitzel,
  • Lorna H. McNeill

摘要

Purpose

To appraise financial toxicity (FT) among women receiving care for breast cancer during the COVID-19 pandemic and determine sociodemographic, clinical, psychosocial, and care-disruption factors linked to greater financial hardship.

Methods

Forty-eight survivors (mean age = 45.3 ± 10.9 years; 42% Black, 42% non-Hispanic White, 17% Hispanic/Latina) completed an online survey. FT was measured with the COST-FACIT. Additional instruments assessed perceived stress (PSS-10), coping (Brief-COPE), self-efficacy (CBI-B), social isolation (PROMIS-SF-4a), health-related quality of life (FACT-B), and pandemic-related delays or changes in cancer care. Pearson correlations explored bivariate associations; backward-selection regression identified predictors of FT.

Results

Mean COST score was 21.77 ± 12.33 and 58.3% of survivors met the threshold for mild or moderate FT (< 26). Worse FT correlated with higher psychological distress (p = 0.001), greater social isolation (p = 0.005), and more care disruptions (p < 0.001). Financial security correlated with greater self-efficacy (p = 0.019) and higher health-related quality of life (p < 0.001). In multiple regression analysis (R2 = 0.69), survivors reporting worse quality of life, lower income, and less education reported greater financial toxicity.

Conclusions

Breast cancer survivors experienced substantial FT while navigating care during the pandemic, with greater burden associated with psychological distress, social isolation, care disruptions, and lower socioeconomic status. FT was attenuated among those with higher health-related quality of life and self-efficacy. Integrating proactive financial navigation, psychosocial screening, and targeted support for socioeconomically vulnerable survivors into routine oncology care may mitigate financial hardship and improve overall well-being.